GlassScriptPhysician profile
Jeanette Biller
NPI 1578505178
$649.44
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $508 · 2020: $136 · 2023: $5.33.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5.33.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $88.11 | 2019-2020 | |
| Novo Nordisk INC | $75.22 | 2019-2020 | |
| Abbvie INC. | $70.76 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $57.56 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $48.18 | 2019 | |
| Novartis Pharmaceuticals Corporation | $43.93 | 2019 | |
| Radius Health, INC. | $43.35 | 2019-2020 | |
| Amarin Pharma, INC. | $28.31 | 2019-2020 | |
| Scilex Pharmaceuticals INC. | $28.00 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $27.77 | 2019 | |
| Amgen INC. | $25.19 | 2019-2020 | |
| Smith+Nephew, INC. | $21.06 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $14.97 | 2019 | |
| Janssen Pharmaceuticals, INC | $14.46 | 2019 | |
| Ibsa Pharma INC. | $14.40 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $14.38 | 2019 | |
| Daiichi Sankyo INC. | $14.36 | 2019 | |
| Allergan, INC. | $14.10 | 2019 | |
| Mayne Pharma Commercial LLC | $5.33 | 2023 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeanette Biller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.